Hans Peter Hasler
InvestorCFO & Vorstand - yabeo Impact AG at Yabeo · Präsident (President of the Board of Directors) at HBM Healthcare Investments
Küssnacht am Rigi, Schwyz, Switzerland
Find your path to Hans
245 people in our graph share verified history with Hans — schools, employers, funds. One of them is your warm intro.
About
Hans Peter Hasler has chaired the board of directors of HBM Healthcare Investments since 2009 and serves on its audit committee. He was CEO of Vicarius Pharma from 2017 to 2020 and previously held international leadership roles at Wyeth Pharmaceuticals, Biogen Inc., and Elan Corporation. He holds a Swiss federal commercial diploma and a marketing certificate from the Schweizerisches Institut für Betriebsökonomie (SIB) in Zurich.
Investments
Board seats
Gain TherapeuticsMinerva NeurosciencesShield Therapeutics plc
Per the firm's website.
Colleagues at Yabeo
Frequently asked questions
- Who is Hans Peter Hasler?
- Hans Peter Hasler has chaired the board of directors of HBM Healthcare Investments since 2009 and serves on its audit committee. He was CEO of Vicarius Pharma from 2017 to 2020 and previously held international leadership roles at Wyeth Pharmaceuticals, Biogen Inc., and Elan Corporation. He holds a Swiss federal commercial diploma and a marketing certificate from the Schweizerisches Institut für Betriebsökonomie (SIB) in Zurich.
- Where does Hans Peter Hasler work?
- Hans Peter Hasler is CFO & Vorstand - yabeo Impact AG at Yabeo.
- What boards does Hans Peter Hasler sit on?
- Hans Peter Hasler holds tracked board seats at Gain Therapeutics, Minerva Neurosciences, Shield Therapeutics plc.